Come up with a name for your new list and we'll add to it:
Caprion Pharmaceuticals raised a round of funding on , . Investors include
EdgeStone Capital Partners.
Caprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk an…